• Sotagliflozin (Zynquista): A Novel SGLT Medication
  • Amazing Outcomes with Combination Therapy of GLP-1 Receptor Agonist and SGLT2 Inhibitors
  • Depict-2 Study: Adding an SGLT-2 Inhibitor For Type 1 Diabetes
  • DURATION-8 Trial: Combining a GLP-1 Receptor Agonist Plus an SGLT-2 Inhibitor